Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity, Inc. (NYSE: DOCS) is a digital platform for U.S. medical professionals, and its news flow reflects both its role in healthcare technology and its status as a public company. The company describes itself as the leading digital platform for U.S. medical professionals, with a verified clinical membership that includes more than 80% of U.S. physicians across specialties and practice areas.
News about Doximity often centers on its financial results and guidance. The company regularly issues press releases announcing quarterly and annual results, detailing revenue, net income, operating cash flow, free cash flow, and non-GAAP measures such as adjusted EBITDA and non-GAAP net income. These updates also highlight trends in engagement across its newsfeed, workflow, and AI products.
Another key category of DOCS news involves product and platform developments. Doximity has reported rapid growth in its AI suite, including tools like AI Scribe and DoxGPT, and has announced new AI-powered clinical reference and search capabilities. The acquisition of Pathway Medical Inc., a company specializing in medical AI and evidence-based clinical reference, is an example of transaction-related news that expands its AI and clinical reference offerings.
Doximity also issues research-based news, such as its Physician Compensation Report, which uses survey data from physicians on its platform to examine compensation trends, gender pay gaps, reimbursement pressures, and workforce strain. Additional news items include announcements of upcoming earnings releases, participation in investor conferences, and governance or legal updates disclosed via Form 8-K filings.
Investors and healthcare professionals can use the DOCS news stream to follow earnings announcements, AI and workflow product updates, acquisitions, research reports, and corporate governance developments related to Doximity’s role in the U.S. healthcare and digital health landscape.
Doximity (NYSE: DOCS) reported strong fiscal 2025 Q1 results, with total revenue up 17% year-over-year to $126.7 million. The company saw significant growth in profitability, with net income increasing 46% to $41.4 million and adjusted EBITDA rising 42% to $65.9 million. Doximity's CEO highlighted record engagement, with 590,000 unique providers using their AI, telehealth, messaging, and scheduling tools. The company's non-GAAP net income margin improved to 44.1% from 37.5% year-over-year. For Q2 FY2025, Doximity expects revenue between $126.5-$127.5 million and adjusted EBITDA of $62.5-$63.5 million. The full-year FY2025 guidance projects revenue of $514-$523 million and adjusted EBITDA of $248.5-$257.5 million.
Doximity (NYSE:DOCS), the leading digital platform for U.S. medical professionals, has announced that it will release its fiscal 2025 first quarter financial results on August 8, 2024, after the market closes. The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results. Interested parties can access the live audio webcast on Doximity's Investor Relations page at https://investors.doximity.com/ before the call. A replay of the webcast will be available on the website following the call.
Doximity, a leading digital platform for U.S. medical professionals, announced that CEO Jeff Tangney will present at the William Blair 44th Annual Growth Stock Conference. The presentation is scheduled for Wednesday, June 5, 2024, at 2:00 p.m. Central Time. This event provides Doximity an opportunity to showcase its growth strategies and business developments to potential investors and stakeholders.
Doximity's 2024 Physician Compensation Report reveals a 5.9% increase in average physician compensation in 2023, following a 2.4% decline the previous year. The report highlights a 23% gender wage gap, with male physicians earning nearly $102,000 more than female physicians. Additionally, 81% of physicians feel overworked, with 59% considering employment changes, including early retirement. The physician shortage continues to impact 88% of respondents, with 86% expressing concern over the healthcare system’s ability to care for an aging population.
Doximity (NYSE: DOCS) announced their Q4 and Fiscal Year 2024 financial results. For the fiscal year, total revenues reached $475.4 million, a 13% increase year-over-year, and net income grew by 31%. Q4 revenues were $118.1 million, showing a 6% increase. Adjusted EBITDA for the fiscal year rose by 25%, and net income margins improved from 26.9% to 31%. The company reported a diluted net income per share for the fiscal year of $0.72, up from $0.53. Doximity also introduced a $500 million stock repurchase program. The company's financial outlook for fiscal year 2025 includes revenues between $506 million and $518 million, and adjusted EBITDA between $238 million and $250 million.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Doximity (DOCS)?
What is the market cap of Doximity (DOCS)?
